Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma

por Wang, Chao, Li, Yan, Chu, Chuan-min, Zhang, Xiang-min, Ma, Jie, Huang, Hai, Wang, Yu-ning, Hong, Tian-yu, Zhang, Jing, Pan, Xiu-wu, Zheng, Jing-cun, Jiang, Ning, Hu, Chuan-yi, Ma, Xiaojing, Sun, Ying-hao, Cui, Xin-gang
Publicado 2018